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Interleukin  2  (IL-2  or  T  cell  growth  factor)  is  a  15,500  Mr  glycoprotein 
critically involved in the development of the normal immune response (1, 2). IL- 
2 acts through specific interactions with membrane receptors expressed on the 
surface of activated but not resting T  cells (3, 4). Using the anti-Tac monoclonal 
antibody  (5-7),  we  purified  human  IL-2  receptor  from  HTLV-I  (human  T 
lymphotrophic virus  I)-infected HUT  102B2  leukemic T  cells, determined its 
NHz-terminal  sequence,  and  isolated cDNAs  encoding the  protein  (8).  Other 
investigators, using a different HTLV-I-infected cell line (9) and a different anti- 
IL-2 receptor antibody (10), have reported similar results. Previously (11-14), it 
was demonstrated that HUT  102B2 IL-2 receptors were ~5,000 daitons smaller 
than  the  receptors  on  normal  activated  T  cells,  at  least  in  part  reflecting 
differences in posttranslational processing (12). 
Recently (15),  radiolabeled  IL-2-binding assays  with  activated  T  cells  have 
demonstrated the presence of both high and low affinity IL-2 receptors that are 
indistinguishable in radiolabeled anti-Tac-binding assays. While the molecular 
basis  for  these  affinity differences remains  unresolved,  the  growth-promoting 
effects of IL-2 appear to be mediated by interaction of IL-2 with the high affinity 
receptor (3,  15). 
Using  a  cotransfection  technique  and  an  SV40  expression  vector,  we  now 
report  stable  expression  in  mouse  L  cells  of an  HUT  102B2-derived  IL-2 
receptor cDNA.  Our  findings indicate that: (a)  the aberrant  size of the HUT 
102B2 receptor is recapitulated in these transfected L cells, (b) exogenous IL-2 
does not augment the proliferation of transfected L cells, and (c) the expressed 
receptors exclusively exhibit a low apparent binding affinity for human IL-2. 
Materials and Methods 
Radiolabeled  Probes.  Purified monoclonal anti-Tac (anti-human IL-2 receptor anti- 
body) was radiolabeled with tritium as previously described (16). Jurkat IL-2 was biosyn- 
thetically labeled with [3H]leucine  and [3H]lysine and purified (3,  17). Two independent 
3  preparations of [ H]IL-2 with specific radioactivities of 4.49 x  10 h dpm/pmoi and 1.52 x 
104 dpm/pmol were used to measure, respectively, high and low affinity receptors (15). 
Construction  ofpcEXV-I-IL-2R-3.  The expression vector pcEXV-1,  which contains the 
SV40 early promoter and enhancer sequences, was the gift of Drs. Ron Germain and Jim 
Miller, National Institutes of Health. The 2,335 base pair (bp) cDNA insert of pIL-2R-3 
(8)  was ligated into the EcoRI site of pcEXV-1,  and plasmids with correctly oriented 
inserts were isolated. 
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Transfection  of Tk- L Cells.  Using calcium phosphate precipitation, thymidine kinase- 
deficient (Tk-) murine  L  cells  were cotransfected with pcEXV-I-IL-2R3  DNA  (5  #g/ 
plate), pUC8-Tk plasmid DNA (60 ng/plate), and high molecular weight carrier DNA 
(15  #g/plate)  (18).  On  day  2  of culture,  medium  containing  hypoxanthine (10  -4  M), 
aminopterin (4 ×  l0  -7 m), and thymidine (1.6 ×  10  -5 M) (HAT) was added. After 10-14 
d of culture, HAT-resistant colonies were isolated and expanded. 
Analysis of Receptor Structure and Function.  L cells were removed from tissue culture 
flasks by incubation in phosphate-buffered saline containing 0.5 mM EDTA, for 15 rain 
at 37 ° C. Surface iodination and anti-Tac immunoprecipitation were performed as previ- 
ously  described  (6).  Potential  IL-2-induced  proliferation  of  L  cell  transfectants  was 
evaluated by measuring [3H]thymidine incorporation 24 and 48 h after addition of  purified 
Jurkat IL-2 (6.5 pM, 6.5 nM, and 200 nM final concentrations). Radioreceptor binding 
assays  using [SH]anti-Tac and [SH]IL-2  were performed as previously described (3,  15, 
16). 
Results 
The  expression  vector  pcEXV-I-IL-2R3  is  depicted  in  Fig.  1,  left.  After 
chromosomal integration, this vector permits stable expression of cDNA under 
the control of the SV40 early promoter and enhancer sequences. After transfec- 
tion,  seven different  HAT-resistant  L  cell transfectants,  designated  L-TRANS 
1-7,  were chosen  for detailed analysis.  Each of these cell populations,  but not 
nontransfected L cells, expressed human IL-2 receptors as measured both by the 
binding  of [3H]anti-Tac  and  indirect  immunofluorescence  with  anti-Tac  (80- 
90%  of cells  were  positive).  The  level  of IL-2  receptor  expression,  however, 
varied significantly among the L  cell colonies (1,500-18,000 receptors per ceil), 
with L-TRANS 3 consistently displaying the greatest number of receptors. 
To characterize the IL-2 receptors expressed, we radiolabeled proteins on the 
surface of L-TRANS 3 and HUT  102B2 cells with Na[125I], and immunoprecip- 
itated with anti-Tac or UPC-10 (a control murine IgG2aK monoclonal antibody) 
FIGURE  1.  (Left)  Schematic of the  3.0  kb  pcEXV-I-IL-2R3  expression vector  used  for 
cotransfection. (Right) Surface iodination and immunoprecipitation of L-TRANS 3 and HUT 
102B2 cells. (A) L-TRANS 3-UPC-10; (B) HUT 102B2-UPC-10; (C) L-TRANS 3-anti-Tac; 
(D) HUT 102B2-anti-Tac. GREENE  ET  AL.  BRIEF  DEFINITIVE  REPORT  365 
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FIGURE 2.  Measurement of high affinity IL-2 receptor expression in  L-TRANS 3 and L- 
TRANS 4  cells (A) and HUT  102B2  ceils (B). Scatchard conversion of the binding data is 
shown as an inset in each panel. 
(Fig. 1, right). Anti-Tac, but not UPC-10, identified ]L-2 receptors on L-TRANS 3 
cells that  were essentially identical  in size (Mr 50,000) to the receptors present 
on  HUT  102B2  cells,  but  ~5,000  daitons  smaller  than  the  receptors  isolated 
from lectin-activated, normal peripheral blood lymphocytes (11-14). Despite the 
presence of IL-2 receptors, purified IL-2 (final concentrations, 6.5 pM, 6.5 riM, 
or 200 riM) did not augment [3H]thymidine incorporation  at 24 or 48 h  in any 
of the  L  cell  transfectants.  These preparations  of IL-2,  however, did promote 
maximal proliferation of a cloned, IL-2-dependent murine,  cytotoxic T  cell line 
(CTLL-2), similarly exposed to EDTA. 
Using purified [3H]IL-2, Robb, Greene, and Rusk (15) have recently identified 
at  least  two  affinity  classes  of IL-2  receptors  on  lectin-activated  T  cells  and 
HTLV-infected leukemic T  cell lines. In contrast to IL-2, the anti-Tac antibody 
bound equivalently to both affinity classes of receptors and  thus could not be 
used to distinguish these binding site populations. The less numerous high affinity 
receptors  (Kd  [dissociation  constant]  10 -ll  M) appear  to  mediate  the  growth- 
promoting  response  to  IL-2  (3,  15),  while  the  more  numerous  low  affinity 
receptors (Ka 10  -8 M) have, as yet, no defined biological function. In the presence 
of  100  pM  free  IL-2,  neither  L-TRANS  3  nor  L-TRANS  4  cells  displayed 
significant  numbers  of high  affinity IL-2-binding sites (~10 receptors per cell) 
(Fig.  2A).  In  contrast,  at  the  same  IL-2  concentrations,  HUT  102B2  cells 366 
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FmURE  3.  (Left)  Measurement of low affinity IL-2 receptor expression in L-TRANS 3 and 
L-TRANS  4  cells.  Simultaneous studies  with  HUT  102B2  cells  demonstrated  82,000  low 
affinity receptors with a  Kd of 2.88  X  10 -s M.  Scatchard conversion of the binding data  is 
shown in the inset in both panels. (Right) Measurement of anti-Tac binding sites on L-TRANS 
3 and L-TRANS 4  cells. Simultaneous binding studies with HUT  102B2  cells demonstrated 
185,000  receptors per cell with a Kd of 1.5 ×  10  -]°. 
TABLE  I 
IL-2 Receptor Number and Affinity 
Cell type 
Sites per 
cell  Kd 
1L-2 Binding*  Anti-Tac  binding*  High affinity 
I L-2-binding 
High affinity  Low affinity  sites as a per- 
Sites per  Sites per cell  Kd  centage  of 
cell  Kd  anti-Tac  sites 
pM  pM  pM  % 
HUT 102B2  5, ] 50  6.1  82,000  28,000  185,000  ] 50  2.8 
L-TRANS 3  ~10  --  11,000  28,800  18,000  130  -<0.06 
L-TRANS 4  -<5  --  5,000  24,200  6,000  110  <-0.08 
* Two independent preparations of [SH]leu,lys IL-2 were used to measure binding, one with a specific radioactivity 
of 4.49  x  105 dpm/pmol (high affinity  binding),  and the other,  1.52 ×  104 dpm/pmol (low affinity  binding). 
The results were first corrected for nonspecific binding. 
* Anti-Tat antibody  was radiolabeled  by reductive  metbylation  using [~H]NaBH4 to a specific radioactivity of 3.59 
x  105 dpm/pmol. 
similarly exposed to EDTA bound (Ka 6.1  x  10 -12  M)  ~5,100  molecules of [3H] 
1L-2 per cell (Fig. 2B). With regard to low affinity IL-2 receptors,  L-TRANS 3 
and  L-TRANS 4  cells expressed  11,000  and  5,000  sites per cell,  respectively, 
(Ka 2.88 X 10  -8 M and 2.42 X 10  -8 M), compared with 82,000 sites per cell for 
the HUT 102B2 cell line (Ka 2.88 x  10 -8 M) (Fig. 3, leftand Table I). The small 
amount of specific [3H]IL-2 binding that occurred on L-TRANS 3 and 4 cells at 
200-400 pM free IL-2 (Fig. 2A) may represent a portion of the binding to these 
low affinity receptors.  [3H]Anti-Tac  binding  to  L-TRANS  3 and  L-TRANS 4 
cells (Fig.  3, right)  was 18,000 and 6,000 sites per cell, respectively, which is in 
general  agreement  with the [3H]lL-2-binding data.  Table  I presents aggregate 
results  from  these  binding  studies  and  indicates  that  the  L  cell  transfectants 
express  a  typical  low  affinity  but  essentially  no  detectable  high  affinity  IL-2 
receptors. 
Discussion 
Using  an  SV40  expression  vector  and  a  cDNA  encoding  the  human  IL-2 
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IL-2 receptors for >4 mo in culture. These L cell transfectants (a) bound [~H]- 
anti-Tac and displayed receptors identical in size to those on HUT  102B2 cells 
from which the cDNA was isolated, (b) failed to respond to IL-2 with increased 
proliferation,  and  (c) expressed low affinity but not high  affinity forms of the 
IL-2 receptor. 
These findings underscore two major points.  First,  transfection  of the HUT 
102B2-derived  IL-2 receptor cDNA resulted in a  display of surface receptors 
having the aberrant size of the IL-2 receptors present on HUT  102B2 cells (Mr 
50,000  rather  than  55,000).  Similar  results  have  been  obtained  with  COS-1 
monkey kidney cells in  transient  expression studies.  While the molecular basis 
for  the  difference  in  HUT  102B2  receptor  size  appears  to  reside  in  altered 
posttranslational  processing (12), these findings raise the possibility that a differ- 
ence in the primary  DNA sequence may produce this difference in processing. 
Alternatively,  I~ cells and COS-1  cells may share with HUT  102B2 cells similar 
abnormalities of posttranslational  processing of the human  IL-2 receptor.  Final 
resolution of a potential difference in primary structure of the normal and HUT 
102B2 IL-2 receptor awaits complete determination of the normal IL-2 receptor 
gene or cDNA sequence. 
Second, although  expressing the Tac antigen,  the transfected L cells did not 
respond to purified IL-2 with augmented proliferation.  This lack of responsive- 
ness could reflect the malignant nature of these cells or tissue-specific restrictions 
of IL-2 responsiveness perhaps due to the absence of an appropriate  apparatus 
to  transmit  intracellular  signals.  However,  the  finding  that  only  low  affinity 
IL-2  receptors are  expressed  in  these  transfected  cells provides an  alternative 
explanation  for  the  lack  of augmented  proliferation,  since  high  but  not  low 
affinity, IL-2 receptors appear to mediate IL-2-induced growth.  At present, the 
molecular  basis  for  differences  in  IL-2  receptor  affinity  remains  undefined. 
Possible mechanisms  that  might  produce receptors  with  high  affinity for  IL-2 
include (a) formation of a receptor complex and (b) posttranslational  modifica- 
tion of the receptor protein.  Alternatively, it is possible that the cDNA isolated 
from the HUT  102B2 cells encodes only the low affinity IL-2 receptor. 
Additional  study of the structural  and functional differences in the high and 
low affinity  forms  of the  IL-2  receptor  is  required.  The  availability  of a  cell 
population  that  expresses  only  low  affinity  receptors,  however,  should  help 
elucidate these differences and provide possible insights  into  the  mechanism(s) 
of signal transmission  used by the 1L-2 receptor. 
Summary 
Human interleukin  2  (IL-2) receptor cDNA derived from HUT  102B2 cells 
was stably expressed in murine  L cells. These  L cell transfectants  (a) displayed 
surface receptors of the aberrant size of the IL-2 receptors on HUT 102B2 cells, 
(b) did not  respond  to exogenous IL-2  with  augmented  proliferation,  and  (c) 
expressed low affinity but not high affinity receptors for IL-2. 
We wish to thank Drs. Robert Cunningham and Phillip Noguchi of the Center for Drugs 
and Biologics, Food and Drug Administration,  for performing the flow microfluorometric 
studies. 
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